Agios Pharmaceuticals (AGIO) Net Margin (2016 - 2025)
Historic Net Margin for Agios Pharmaceuticals (AGIO) over the last 12 years, with Q4 2025 value amounting to 541.09%.
- Agios Pharmaceuticals' Net Margin rose 3584700.0% to 541.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 767.3%, marking a year-over-year decrease of 26044200.0%. This contributed to the annual value of 764.01% for FY2025, which is 26099400.0% down from last year.
- Agios Pharmaceuticals' Net Margin amounted to 541.09% in Q4 2025, which was up 3584700.0% from 803.05% recorded in Q3 2025.
- Over the past 5 years, Agios Pharmaceuticals' Net Margin peaked at 10574.69% during Q3 2024, and registered a low of 1471.24% during Q1 2023.
- In the last 3 years, Agios Pharmaceuticals' Net Margin had a median value of 1026.7% in 2025 and averaged 90.77%.
- Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 118089600bps in 2024, then plummeted by -113777400bps in 2025.
- Quarter analysis of 3 years shows Agios Pharmaceuticals' Net Margin stood at 1350.7% in 2023, then soared by 33bps to 899.56% in 2024, then soared by 40bps to 541.09% in 2025.
- Its last three reported values are 541.09% in Q4 2025, 803.05% for Q3 2025, and 903.6% during Q2 2025.